Effect of Lifestyle-related factors on developing end-stage renal disease (ESRD)

生活方式相关因素对终末期肾病(ESRD)发展的影响

基本信息

  • 批准号:
    17590835
  • 负责人:
  • 金额:
    $ 1.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2007
  • 项目状态:
    已结题

项目摘要

Effect of Lifestyle-related factors on developing end-stage renal disease (ESRD)There will be more than 2 million dialysis patients in the world by 2010, approximately 0.3 million in Japan alone. Community-based screening programs have provided data for several papers on this topic. Among them, the Okinawa General Health Maintenance Association, a nonprofit organization founded in 1972, conducts an annual large community-based health examination screening program. Approximately 14% of the total adult population of Okinawa participated in each screening. The ESRD patient registry in Okinawa was used to investigate the outcome of the screenees. All chronic dialysis patients residing in the prefecture who survived for at least 1 month on scheduled dialysis were included in the registry. All patients (n=5246) were followed-up until the occurrence of a major medical event or until January 2001, whichever occurred first, and all outcomes were verified.Using the two registries, we identified … More screening participants who later entered a dialysis program. Furthermore, patient data were verified by medical records. Important predictors of developing ESRD are dipstick・positive proteinuria and hypertension. Low GFR per se, which is often observed in the elderly population, is not a strong predictor of developing ESRD unless associated with proteinuria. Other significant risk factors are obesity and metabolic syndrome. Both the prevalence and incidence of CKD increase with an increase in the number of components of metabolic syndrome. The relationship between baseline BMI and the cumulative incidence of ESRD is linear, particularly in men, but a similar trend in both men and women has been reported.Incidence and prevalence of CKD are closely related with the lifestyle such as diet, exercise, tobacco, and other cultural differences. Research on the relationship between CKD and metabolic syndrome may provide clue to understand better the role of lifestyle related factors and the age-related decline in GFR. Early detection and treatment of metabolic syndrome would be one of the cost-effective strategy for ever increasing prevalence of ESRD. Therefore, subjects with metabolic syndrome are candidates for the screening of CKD through dipstick proteinuria and measurement of serum creatinine. Less
生活方式相关因素对终末期肾病(ESRD)发展的影响到2010年,全世界将有超过200万透析患者,仅日本就有大约30万。以社区为基础的筛查项目为这一主题的几篇论文提供了数据。其中,成立于1972年的非营利组织冲绳综合健康维护协会(Okinawa General Health Maintenance Association)每年都会开展大型社区健康检查筛查项目。约有14%的冲绳成年人口参加了每次筛查。冲绳县ESRD患者登记处被用来调查筛选者的结果。所有居住在该县并在计划透析中存活至少1个月的慢性透析患者均被纳入登记。对所有患者(n=5246)进行随访,直到发生重大医疗事件或直到2001年1月,以先发生者为准,并对所有结果进行验证。通过这两个登记,我们发现…更多的筛查参与者后来进入了透析计划。此外,还通过医疗记录核实了患者数据。尿试纸阳性蛋白尿和高血压是发生ESRD的重要预测因素。低GFR本身,通常在老年人群中观察到,除非与蛋白尿相关,否则不是发生ESRD的有力预测因素。其他重要的危险因素是肥胖和代谢综合征。CKD的患病率和发病率都随着代谢综合征组成部分数量的增加而增加。基线BMI与ESRD的累积发病率之间的关系是线性的,尤其是在男性中,但在男性和女性中也有类似的趋势。CKD的发病和流行与生活方式如饮食、运动、吸烟等文化差异密切相关。研究CKD与代谢综合征之间的关系,可以为更好地理解生活方式相关因素在GFR年龄相关性下降中的作用提供线索。早期发现和治疗代谢综合征将是一个具有成本效益的策略,为日益增加的ESRD患病率。因此,代谢综合征患者是通过尿量尺检测蛋白尿和测定血清肌酐筛查CKD的候选者。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
慢性腎臓病と心血管疾患「心腎連関:わが国のエビデンス」肥満、メタボリック症候群とCKDの関連:臨床疫学的検討
慢性肾病和心血管疾病“心肾联系:来自日本的证据”肥胖、代谢综合征和 CKD 之间的关系:临床流行病学回顾
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kunitoshi Iseki;et al.;井関邦敏
  • 通讯作者:
    井関邦敏
Screening for renal disease - what can be learned from Okinawa experience
肾脏疾病筛查——冲绳经验值得借鉴
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tanaka H;Shiohira Y;Uezu Y;Higa A;Iseki K.;Iseki K
  • 通讯作者:
    Iseki K
Prevalence of CKD among sleep apnea syndrome The 50^<th> Japanese Society of Nephrology meeting
睡眠呼吸暂停综合征中 CKD 的患病率第 50 届日本肾脏病学会会议
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kunitoshi Iseki;et al.
  • 通讯作者:
    et al.
Significance of coronary artery calcification score (CACS)for the detection of coronary artery disease (CAD)in chronic hemodialysis patients
冠状动脉钙化评分(CACS)对慢性血液透析患者冠状动脉疾病(CAD)检测的意义
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fujimoto N;Iseki K;Tokuyama K;Tamashiro M;Takishita S.
  • 通讯作者:
    Takishita S.
Chronic kidney disease and the risk of developing cardiovascular disease events : A community-based approach
慢性肾病和发生心血管疾病事件的风险:基于社区的方法
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Iseki K;Iseki C;Okumura K;Kinjo K;Takishita S.
  • 通讯作者:
    Takishita S.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISEKI Kunitoshi其他文献

ISEKI Kunitoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISEKI Kunitoshi', 18)}}的其他基金

Urasoe Model; A Comprehesive Study the Natural Course and Treatment Practice of CKD in Urasoe, Okinawa
浦添模型;
  • 批准号:
    22590894
  • 财政年份:
    2010
  • 资助金额:
    $ 1.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Outcomes and perspectives on treatment for critical limb ischemia in patients with end-stage renal disease
终末期肾病患者严重肢体缺血治疗的结果和前景
  • 批准号:
    10673924
  • 财政年份:
    2022
  • 资助金额:
    $ 1.18万
  • 项目类别:
Integrative molecular characterization of renal cell carcinoma arising in end-stage renal disease
终末期肾病肾细胞癌的综合分子特征
  • 批准号:
    22K16797
  • 财政年份:
    2022
  • 资助金额:
    $ 1.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Outcomes and perspectives on treatment for critical limb ischemia in patients with end-stage renal disease
终末期肾病患者严重肢体缺血治疗的结果和前景
  • 批准号:
    10525416
  • 财政年份:
    2022
  • 资助金额:
    $ 1.18万
  • 项目类别:
Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease
终末期肾病中的结构性种族主义、复原力和过早认知衰老
  • 批准号:
    10471530
  • 财政年份:
    2022
  • 资助金额:
    $ 1.18万
  • 项目类别:
Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease
终末期肾病中的结构性种族主义、复原力和过早认知衰老
  • 批准号:
    10659198
  • 财政年份:
    2022
  • 资助金额:
    $ 1.18万
  • 项目类别:
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease
扩大医疗保险优惠覆盖范围对终末期肾病患者的影响
  • 批准号:
    10435533
  • 财政年份:
    2021
  • 资助金额:
    $ 1.18万
  • 项目类别:
Optimizing Pain Management in End-Stage Renal Disease Among Veterans (OPERA-Vets):Balancing Benefits and Harms of Opioids
优化退伍军人终末期肾病的疼痛管理 (OPERA-Vets):平衡阿片类药物的利弊
  • 批准号:
    10668961
  • 财政年份:
    2021
  • 资助金额:
    $ 1.18万
  • 项目类别:
Optimizing Pain Management in End-Stage Renal Disease Among Veterans (OPERA-Vets):Balancing Benefits and Harms of Opioids
优化退伍军人终末期肾病的疼痛管理 (OPERA-Vets):平衡阿片类药物的利弊
  • 批准号:
    10185425
  • 财政年份:
    2021
  • 资助金额:
    $ 1.18万
  • 项目类别:
Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)
终末期肾病肺动脉高压的新机制和治疗靶点(K23)
  • 批准号:
    10666408
  • 财政年份:
    2021
  • 资助金额:
    $ 1.18万
  • 项目类别:
Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)
终末期肾病肺动脉高压的新机制和治疗靶点(K23)
  • 批准号:
    10301844
  • 财政年份:
    2021
  • 资助金额:
    $ 1.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了